The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Efficacy of beta 2-Agonists in Bronchiolitis: A Reappraisal and Meta-analysis
Abstract
OBJECTIVE: To evaluate the efficacy of beta2-agonists in bronchiolitis. DESIGN: Critical review and meta-analysis of randomized controlled trials of inhaled beta2-agonists. RESULTS: Three inpatient and five outpatient studies were identified. Inpatient studies (82 patients) were characterized by wide variability in therapeutic regimens and measurement of outcomes. Several problems were identified in the selection and specification of patients, such as failure to assess the prestudy duration of illness or to exclude patients already taking bronchodilators. Meta-analysis was not possible for inpatient trials due to the great variability in study outcomes, timing of outcome assessment, and drug regimens. Results of inpatient trials were contradictory: one found significant reductions in the clinical score and a shorter hospital stay with treatment, whereas two others found only significant oxygen desaturations. Outpatient studies (251 patients) examined immediate changes in physiologic measures and clinical scores after two treatments, but have not examined the effects of the longer-term regimen customarily used by clinicians. Meta-analysis revealed that short-term beta2-agonist therapy had no impact on the hospitalization rate or respiratory rate, and had a statistically significant but clinically insignificant impact on oxygen saturation and heart rate. The diversity of scoring systems precluded pooling of clinical score data. CONCLUSIONS: Despite eight clinical trials, conclusive evidence for the efficacy of beta2-agonist therapy for bronchiolitis remains unavailable. Well-designed inpatient trials are needed. Meta-analysis of outpatient studies does not support the use of beta2-agonist therapy for bronchiolitis, but investigators have not studied the outcomes and the long-term outpatient regimen customarily used by clinicians.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE COMPARISON OF PERCENTAGES IN MATCHED SAMPLES
COCHRAN, W. G. (1950) · Biometrika · doi:10.1093/biomet/37.3-4.256 · Cited by 1,465
Cited by
Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
Ralston, S. L., Lieberthal, A. S., Meissner, H. C., Alverson, B. K., Baley, J. E., Gadomski, A. M., Johnson, D. W., Light, M. J., Maraqa, N. F., Mendonca, E. A., et al. (2014) · Pediatrics · doi:10.1542/peds.2014-2742 · Cited by 1,733
Diagnosis and Management of Bronchiolitis
Bronchiolitis, S. O. D. A. M. O. (2006) · Pediatrics · doi:10.1542/peds.2006-2223 · Cited by 1,062
Bronchodilators for bronchiolitis
Gadomski, A. M., & Scribani, M. B. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001266.pub4 · Cited by 522
Shay, D. K., Holman, R. C., Roosevelt, G. E., Clarke, M. J., & Anderson, L. J. (2001) · The Journal of Infectious Diseases · doi:10.1086/317655 · Cited by 464
Glucocorticoids for acute viral bronchiolitis in infants and young children
Fernandes, R. M., Bialy, L. M., Vandermeer, B., Tjosvold, L., Plint, A. C., Patel, H., Johnson, D. W., Klassen, T. P., & Hartling, L. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004878.pub4 · Cited by 395
Metadata
- Authors
- Flores, G., & Horwitz, R. I.
- Venue
- PEDIATRICS
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 1997-08-01
- Volume
- 100
- Issue
- 2
- Pages
- 233-239
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W1975190325
- Cited by
- 213
- References
- 1
- FWCI
- 9.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of beta 2-Agonists in Bronchiolitis: A Reappraisal and Meta-analysis. https://app.cochat.ai/papers/10.1542/peds.100.2.233
- The paper
- Flores, G., & Horwitz, R. I. (1997). Efficacy of beta 2-Agonists in Bronchiolitis: A Reappraisal and Meta-analysis. PEDIATRICS. https://doi.org/10.1542/peds.100.2.233
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.